deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT03462017

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Study to Assess the Pharmacodynamic Effects of Repeated Oral Doses of SAR247799 on Endothelial Function in Male and Female Patients With Type 2 Diabetes Mellitus

Sponsor: Sanofi

Conditions Microvascular Coronary Artery Disease
Interventions Acetylcholine Placebo SAR247799 Sildenafil
Updated 12 times since 2018 Last updated: Apr 21, 2022 Started: Mar 7, 2018 Primary completion: Dec 22, 2018 Completion: Dec 22, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03462017, this PHASE1 trial focuses on Microvascular Coronary Artery Disease and remains completed. Sponsored by Sanofi, it has been updated 12 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotNot Yet Recruiting~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotRecruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotRecruiting~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshotRecruiting~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshotRecruiting~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshotRecruiting~Feb 2019 – ~Jan 2020 · 11 months · monthly snapshotCompleted~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotCompleted~Jan 2021 – ~May 2022 · 16 months · monthly snapshotCompleted~May 2022 – ~Jul 2024 · 26 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. May 2022 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — May 2022 [monthly]

    Completed PHASE1

  5. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 7 earlier versions

  1. Feb 2019 — Jan 2020 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  2. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE1

  3. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE1

  4. Aug 2018 — Nov 2018 [monthly]

    Recruiting PHASE1

  5. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1

  6. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  7. Mar 2018 — Apr 2018 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sanofi
Data source: Sanofi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations